Standard

Enzyme processivity as a drug target : The case of poxvirus uracil-DNA glycosylase. / Zharkov, D.

In: FEBS Journal, Vol. 284, 09.2017, p. 11-11.

Research output: Contribution to journal › Meeting Abstract › peer-review

Harvard

Zharkov, D 2017, 'Enzyme processivity as a drug target: The case of poxvirus uracil-DNA glycosylase', FEBS Journal, vol. 284, pp. 11-11.

APA

Zharkov, D. (2017). Enzyme processivity as a drug target: The case of poxvirus uracil-DNA glycosylase. FEBS Journal, 284, 11-11.

Vancouver

Zharkov D. Enzyme processivity as a drug target: The case of poxvirus uracil-DNA glycosylase. FEBS Journal. 2017 Sept;284:11-11.

Author

Zharkov, D. / Enzyme processivity as a drug target : The case of poxvirus uracil-DNA glycosylase. In: FEBS Journal. 2017 ; Vol. 284. pp. 11-11.

BibTeX

@article{ccd26279e22243b2afa6cf272711a4db,
title = "Enzyme processivity as a drug target: The case of poxvirus uracil-DNA glycosylase",
author = "D. Zharkov",
year = "2017",
month = sep,
language = "English",
volume = "284",
pages = "11--11",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
note = "42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back ; Conference date: 10-09-2017 Through 14-09-2017",

}

RIS

TY - JOUR

T1 - Enzyme processivity as a drug target

T2 - 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back

AU - Zharkov, D.

PY - 2017/9

Y1 - 2017/9

M3 - Meeting Abstract

VL - 284

SP - 11

EP - 11

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

Y2 - 10 September 2017 through 14 September 2017

ER -

ID: 18734641